Publications by authors named "C L Melchior"

Article Synopsis
  • A nationwide study in France assessed the effectiveness of fecal microbiota transplantation (FMT) for treating Clostridioides difficile infection (CDI) across 17 centers from 2018 to 2022.
  • The study found an overall FMT success rate of 84.3% with very few severe adverse events, and it identified factors linked to CDI recurrence such as severe chronic kidney disease and inadequate bowel cleansing.
  • Key factors for improving FMT success included proper manufacturing of the transplant, thorough bowel prep, and individualized delivery methods based on patient needs.
View Article and Find Full Text PDF

Background: The combination of encorafenib with cetuximab has become the standard of care in patients with BRAF V600E-mutated metastatic colorectal cancer (mCRC) after a prior systemic therapy. This study aims to describe the efficacy and safety of encorafenib/cetuximab +/- binimetinib in patients with BRAF V600E-mutated mCRC in a real-world setting.

Patients And Methods: This retrospective study included patients with BRAF V600E-mutated mCRC who received this combination from January 2020 to June 2022 in 30 centers.

View Article and Find Full Text PDF

The demand for open data and open science is on the rise, fueled by expectations from the scientific community, calls to increase transparency and reproducibility in research findings, and developments such as the Final Data Management and Sharing Policy from the U.S. National Institutes of Health and a memorandum on increasing public access to federally funded research, issued by the U.

View Article and Find Full Text PDF

Data are limited regarding gastrointestinal motility disturbance in disorders of gut-brain interaction (DGBI). This study aimed to characterize antroduodenal motor alterations in patients with high-resolution antroduodenal manometry (HR-ADM). HR-ADM was performed in patients with severe DGBI and compared with healthy volunteers (HV).

View Article and Find Full Text PDF

Objective: The gold standard of oral cancer (OC) treatment is diagnostic confirmation by biopsy followed by surgical treatment. However, studies have shown that dentists have difficulty performing biopsies, dental students lack knowledge about OC, and surgeons do not always maintain a safe margin during tumor resection. To address this, biopsies and resections could be trained under realistic conditions outside the patient.

View Article and Find Full Text PDF